For patient information click here

Multiple myeloma
Bone marrow aspiration in multiple myeloma. (Image courtesy of Melih Aktan M.D.)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2] "sandbox:SN"

Template:Pernicious Anemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief:

Overview[edit source]

Pernicious anemia (also called Addison's anemia) is a type of red blood cell disorder caused by impaired vitamin B12 metabolism. Vitamin B12 is primarily absorbed by the small intestine, after being bound to intrinsic factor secreted by parietal cells of gastric mucosa. When this process is disrupted by conditions like atrophic gastritis, celiac disease, small bowel resection etc, B12 deficiency ensues.

Historical perspective[edit source]

• Pernicious anemia was first discovered by Thomas Addison, hence it is also known as addison's anemia.
• Loss of life from large volume blood loss in the people fighting in the first world war inspired George Whipple to investigate blood forming components such as arsenic, iron pills etc, but found liver to be the most effective. He bled dogs until they had clinical anemia and fed them cooked liver which showed an improvement in symptoms and hematopoeisis. ^[1]
• In 1948, Smith, Rickles et al., isolated the anti-pernicious factor from liver extract and named it Vitamin B12. They showed that even small amounts of this factor can be used to treat and to prevent pernicious anemia. ^[2]

Pathophysiology[edit source]

Vitamin B12 is an essential vitamin for humans and animals because we cannot synthesise it on our own. B12 is a cofactor in DNA synthesis and other important biochemical reactions. Vitamin B12 deficiency manifests as anemia because hematopoetic stem cells in the bone marrow which are rapidly dividing need B12 for division and DNA production. This process is impaired leading to ineffective hematopoeisis. Vitamin B12 is also necessary for production of myelin which is an important component in the covering sheath of nerves. Deficiency results in improper nerve conduction due to nerve destabilisation. ^[3]

Physiology[edit source]

• Vitamin B12 is also called cobalamin because it contains cobalt at the core of its structure. Dietary sources of vitamin B12 include meat, fish and eggs.^[4]
• When consumed through its dietary source, B12 is bound to protein till it enters the stomach.
• In the stomach, B12 is uncoupled from its carrier protein due to the presence of gastric acid, which is why vitamin B12 deficiency is so commonly seen among those on chronic antacid medication. ^[5]
• Once in the stomach, it is then bound to gastric R binder, a glycoprotein secreted by the salivary glands till it reaches the duodenum.^[6]
• In the duodenum and jejunum, the pancreatic enzymes digest the gastric R binder and cobalamin is bound to intrinsic factor (IF).
• Intrinsic factor is secreted by the gastric parietal cells. Once bound to IF, vitamin B12 travels up to the ileum where IF is removed and B12 binds with carrier proteins called transcobalamins and this complex is taken up by the liver and bone marrow, among other tissues.
• Inside the cells, the transcobalamin-B12 complex is dissolved and cobalamin is reduced to methylcobalamin which serves as a cofactor and coenzyme in many important biochemical reactions^[7].

The two major reactions involving B12 in the human body are:

• Vitamin B12 in the from of cyanocobalamin is required in the synthesis of methionine. Methionine is produced from homocysteine and is catalysed by the enzyme methionine synthase. This enzyme utilises cyanocobalamin as a cofactor. Deficiency of vitamin B12 causes a decreased production of methionine and buildup of homocysteine. Hyperhomocysteinemia is implicated as a risk factor in cardiovascular disease.^[8]
• The Kreb's cycle utilises vitamin B12 in the reaction converting methylmalonyl-CoA to succinyl-CoA. Thus vitamin B12 deficiency causes a buildup of methylmalonic acid, the substrate for the enzyme methylmalonyl coenzyme A mutase. Methylmalonic acid levels are elevated in the urine of people affected with pernicious anemia and other forms of B12 deficiency.

Storage[edit source]

The human body can store anywhere from 2-5mg of vitamin B12. Most of this is stored in the liver and is recycled via enterohepatic circulation.

Pathogenesis[edit source]

Pernicious anemia is a type of megaloblastic anemia caused due to improper vitamin B12 absorption by the body. Impaired absorption occurs because of deficiency of intrinsic factor which is produced by the parietal cells of the stomach. The etiology of pernicious anemia can be due to autoimmune causes or genetic disease. In autoimmune disease, the antibodies attack most of the gastric mucosa, but the antrum is spared.

Autoimmune causes of pernicious anemia[edit source]

This is the most common cause of pernicious anemia. In autoimmune pernicious anemia, the body produces antibodies against parietal cells or intrinsic factor.

• Antibodies against parietal cells of the gastric mucosa work to inhibit the H+/K(+)-ATPase which is the proton pump present in the parietal cells. The proton pump serves as an auto antigen and activates the cytotoxic CD4+ T cells which proceed to destroy gastric mucosal cells.^[9][10]
• Intrinsic factor antibodies are present in fewer cases of pernicious anaemia but are highly specific. There are 2 types of IF antibodies. They prevent the binding and absorption of cobalamin in the ileum via its receptor.^[11]

Clinical features[edit source]

• The symptoms of pernicious anemia take months, and often years to manifest. Patients most commonly present with symptoms of anemia like lightheadedness, dizziness, shortness of breath etc. The population affected with pernicious anemia is usually the elderly (>60 years) owing to its insidious onset.
• Pernicious anemia has hematological, gastrointestinal and neurological manifestations.
• Hematological signs are the earliest manifestation of the disease while neurological signs are seen much later.
• Patients with pernicious anemia usually have very low levels of hydrochloric acid in the stomach (achlorhydria) and high levels on gastrin (hypergastrinemia).

Differentiating pernicious anemia from other diseases[edit source]

Pernicious anemia shares many similarities with other forms of megaloblastic anemia like B12 and folate deficiency.

• Vitamin B12 deficiency due to insufficient intake (eg veganism) has all the features of pernicious anemia like megaloblasts, hypersegmented neutrophils, neuropsychiatric manifestations. But atrophic gastritis is absent, so achlorhydria, parietal cell antibodies or IF antibodies are absent. Intrinsic factor levels are also normal.^[6]
• Folic acid deficiency also results in megaloblastic anemia and similar hematological changes as pernicious anemia, but urinary excretion of methylmalonic acid is absent, so are features of pernicious anemia like achlorhydria, antibodies and normal IF levels.
• Ileal resection causes B12 deficiency due to decreased absorption.
• Certain drugs such as methotrexate, azathioprine cause folate deficiency and result in megaloblastic anemia. This is usually seen in patients taking chemotherapy or other chronic conditions such as rheumatoid arthritis. ^[12]
• Chronic proton pump inhibitor therapy also results in B12 deficiency as vitamin B12 cannot dissociate from its carrier protein in the absence of an acidic environment.^[13]
• Long term use of metformin, such as in diabetics, is linked to vitamin B12 deficiency and symptoms similar to pernicious anemia, but this can be differentiated from pernicious anemia as it is seen in diabetics on chronic therapy.^[14]

Associated Conditions[edit source]

People affected with pernicious anemia might have other coexisting autoimmune conditions such as autoimmune thyroiditis, autoimmune diabetes, vitiligo etc. Autoimmune thyroiditis is most commonly seen in patients with pernicious anemia, particularly females. HLA DR3 has been implicated in the development of autoimmune diseases such as pernicious anemia^[15].

Epidemiology and demographics[edit source]

• Pernicious anemia is a disease of the elderly. The mean age of patients who are symptomatic is >60.^[16]
• An exception is the genetic form of the disease which is a congenital deficiency of intrinsic factor and is seen in children <10 years of age.
• Men and women are equally affected
• Prevalence of pernicious anemia is estimated at 0.1% of the population.^[17]

Genetics[edit source]

• Some forms of pernicious anemia are congenital and a genetic link has been postulated because of a higher incidence in certain populations.
• Affected people have a complete or near total absence of intrinsic factor and the presence of antibodies against intrinsic factor.
• The genetic variant is transmitted through an autosomal recessive pattern.^[18]

Risk factors[edit source]

• People who have autoimmune conditions like diabetes mellitus, autoimmune thyroiditis are at higher risk of developing pernicious anemia.

Natural History, Complications and Prognosis[edit source]

• In most cases, patients affected with pernicious anemia remain asymptomatic for many years.
• Early manifestations include fatigue, shortness of breath, pallor and weakness.
• Long standing untreated pernicious anemia results in irreversible neurological damage such as subacute combined degeneration of the spinal cord.
• Neurological changes are irreversible once they set in and do not resolve with cobalamin supplementation.

Diagnosis[edit source]

A diagnosis of pernicious anemia is made by a history and physical examination, along with hematological and neurological examination.

Diagnostic criteria[edit source]

• The only specific criteria to diagnose pernicious anemia is an intrinsic factor output of less than 200U/h after pentagastrin stimulation, where normal levels would be >2000U/h. ^[19]

Symptoms[edit source]

Symptoms of pernicious anemia are summarised below

Physical examination findings[edit source]

Most important physical examination findings are the neurological findings of long standing B12 deficiency which leads to subacute combined degeneration of the spinal cord.

• Hematological signs include pallor and icterus.^[20]
• Neurological signs: Vitamin B12 deficiency causes nerve demyelination. B12 deficiency also causes a buildup of methylmalonic acid which is toxic to neuronal cells and causes apoptosis.^[21].

The main neurological manifestation of pernicious anemia and vitamin B12 deficiency is subacute combined degeneration. The posterior and lateral columns of the spinal cord are affected. Lateral column demyelination manifests as hyperreflexia and spasticity, while posterior column defects are loss of proprioception and vibration sense. Ataxia and loss of tandem gait are also manifestations of posterior column demyelination. Recreational or accidental inhalation of nitrous oxide gas (laughing gas) can precipitate subacute combined degeneration in people with low levels of vitamin B12.^[22]

• Gastrointestinal signs: Upto 25% of people affected with pernicious anemia develop glossitis. The tongue appears red, "beefy" and smooth due to atrophy and blunting of the lingual papillae.^[23]

Subacute combined degeneration

Laboratory findings[edit source]

• The first step in diagnosis is a blood vitamin B12 level. Blood levels less than 200 pg/ml are seen in pernicious anemia.
• Intrinsic factor antibodies and Parietal cell antibodies.
• Low intrinsic factor level.^[24]
• Gastric mucosal sampling shows parietal cell atrophy with antral sparing.^[25]
• Increased level of gastrin.
• Increased levels of homocysteine and methylmalonyl-CoA.
• Decreased folate levels are seen due to "folate trapping" in the form of methyltetrahydrofolate.

Shilling Test[edit source]

The Shilling test is no longer done to detect an IF deficiency but has historical importance. After a vitamin B12 deficiency is noted, the patient is given radioactively tagged cobalamin to take orally. Soon after this step, the patient is injected with unlabelled cobalamin intramuscularly. Urine is checked for radioactive cobalamin for the next 24 hours. In pernicious anemia, there is an intrinsic factor deficiency, therefore the orally consumed radioactive cobalamin will not be absorbed and can be detected in the urine. In the next step, the patient is given radioactive cobalamin along with intrinsic factor and their urine is checked for traces of radioactive cobalamin. Absence of radioactive cobalamin in the urine points to the deficiency of intrinsic factor in the patients stomach which is the cause of vitamin B12 deficiency^[26]. If the cobalamin absorption does not increase even with intrinsic factor supplementation, patient can be given a course of antibiotics as bacterial overgrowth may hinder absorption.

Peripheral smear findings[edit source]

1. The most obvious peripheral smear finding is megaloblasts and macrocytes.

Megaloblastic anemia results due to the lagging behind of nuclear development when compared to cytoplasmic development. This is known as nuclear-cytoplasmic asynchrony. Such defective cells are destroyed in the bone marrow (intramedullary hemolysis).

1. Decreased number of RBCs (erythopenia)
2. Macrocytosis- the RBCs in pernicious anemia are very large. Macrocytosis is defined as cells that have an MCV >100 femtolitres (normal :80-100fL)
3. Hypersegmented neutrophils : Neutrophils containing ≥ 6 lobes. ^[27]
4. Poikilocytosis and anisocytosis
5. Low reticulocyte count (reticulopenia)
6. Howell-Jolly bodies

• 

  Atrophic gastritis

• 

  Hypersegmented neutrophil

Treatment[edit source]

• Standard treatment for pernicious anemia is replacement of cobalamin via intramuscular injection. ^[28]
• 1000 mcg IM everyday for one week, followed by weekly injections the next month and then monthly once injections.
• Response to treatment is measured by an increase in reticulocyte count within 5 days of starting therapy.
• Patient also experience a sense of wellbeing shortly after beginning therapy.
• If reticulocytosis is not observed within the first week of therapy, other factors such as hypothyroidism, folate deficiency should be considered.
• Intramuscular therapy can be replaced by high dose oral therapy.^[17]
• Neurological disease always warrants parenteral treatment.
• Within the first 3-4 weeks of treatment, marrow changes revert and there is resolution in macrocytosis.
• Most patients require lifelong monthly therapy.
• Routine follow up should be done with a CBC every few months.
• A small percentage of patients develop gastric carcinoma, particularly in the elderly. Regular surveillance helps in early detection and treatment. ^[29]

Prevention[edit source]

• There is no primary preventive measure for pernicious anemia.
• Once sucessfully diagnosed and treated, patients with pernicious anemia are followed up every year for development of stomach cancer^[30], or symptoms of anemia.

==References== Shyam Patel [4]

Synonyms and keywords:Kahler disease; Kahler's disease; MM; Myeloma; Myelomatosis; Medullary plasmacytoma; Plasmacytoma

Overview[edit | edit source]

Historical Perspective[edit | edit source]

Classification[edit | edit source]

Pathophysiology[edit | edit source]

Causes[edit | edit source]

Differentiating Multiple Myeloma from other Diseases[edit | edit source]

Epidemiology and Demographics[edit | edit source]

Risk Factors[edit | edit source]

Screening[edit | edit source]

Natural History, Complications and Prognosis[edit | edit source]

Diagnosis[edit | edit source]

Diagnostic Criteria | Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment[edit | edit source]

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies

Case Studies[edit | edit source]

Case #1